Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Opioid antagonists; dispensing and administration by person acting on behalf of an organization. Permits persons acting on behalf of an organization that provides services to individuals at risk of experiencing an opioid overdose or training in the administration of naloxone or other opioid antagonists to dispense other opioid antagonists. The bill also allows persons to whom other opioid antagonists are dispensed to possess and administer such opioid antagonists. Under current law, persons acting on behalf of such organizations may only dispense naloxone. This bill is identical to SB 1035.
Introduced
Jan 3, 2025
Last Action
Mar 24, 2025
Session
VA 2025
Sponsors
1 primary · 0 co
Acts of Assembly Chapter text (CHAP0370)
Approved by Governor-Chapter 370 (Effective 07/01/25)
Governor's Action Deadline 11:59 p.m., March 24, 2025
Enrolled Bill communicated to Governor on February 18, 2025
Signed by President
Fiscal Impact Statement from Department of Planning and Budget (HB1637)
Bill text as passed House and Senate (HB1637ER)
Signed by Speaker
Enrolled
Passed Senate (39-Y 0-N)
Read third time
Constitutional reading dispensed (on 2nd reading) (38-Y 0-N)
Rules suspended
Passed by for the day
Reported from Education and Health (14-Y 0-N)
Referred to Committee on Education and Health
Constitutional reading dispensed (on 1st reading)
Read third time and passed House (93-Y 4-N)
Read second time and engrossed
Read first time
Reported from Health and Human Services (21-Y 1-N)
Subcommittee recommends reporting (7-Y 1-N)
Assigned sub: Health
Fiscal Impact Statement from Department of Planning and Budget (HB1637)
Prefiled and ordered printed; Offered 01-08-2025 25101183D
Referred to Committee on Health and Human Services
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Acts of Assembly Chapter text (CHAP0370)
Patrick A. Hope